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abstract
 
The kinetics of sodium-stimulated phosphate ﬂux and phosphate-stimulated sodium ﬂux in human
 
red cells have been previously described (Shoemaker, D.G., C.A. Bender, and R.B. Gunn. 1988. 
 
J
 
. 
 
Gen
 
. 
 
Physiol
 
. 92:
449–474). However, despite the identiﬁcation of multiple isoforms in three gene families (Timmer, R.T., and R.B.
Gunn. 1998. 
 
Am. J. Physiol. Cell Physiol.
 
 274:C757–C769), the molecular basis for the sodium-phosphate cotrans-
porter in erythrocytes is unknown. Most cells express multiple isoforms, thus disallowing explication of isoform-
 
speciﬁc kinetics and function. We have found that erythrocyte membranes express one dominant isoform, hBNP-1,
 
to which the kinetics can thus be ascribed. In addition, because the erythrocyte Na-PO
 
4
 
 cotransporter can also
 
mediate Li-PO
 
4
 
 cotransport, it has been suggested that this transporter functions as the erythrocyte Na–Li ex-
changer whose activity is systematically altered in patients with bipolar disease and patients with essential hyper-
tension. To determine the molecular basis for the sodium-phosphate cotransporter, we reasoned that if the kinet-
ics of phosphate transport in a nucleated erythroid-like cell paralleled those of the Na-activated pathway in anucle-
ated erythrocytes and yet were distinct from those known for other Na-PO
 
4
 
 cotransporters, then the expressed
genes may be the same in both cell types. In this study, we show that the kinetics of sodium phosphate cotransport
were similar in anuclear human erythrocytes and K562 cells, a human erythroleukemic cell line. Although the
erythrocyte ﬂuxes were 750-fold smaller, the half-activation concentrations for phosphate and sodium and the rel-
ative cation speciﬁcities for activation of 
 
32
 
PO
 
4
 
 inﬂux were similar. Na-activation curves for both cell types showed
cooperativity consistent with the reported stoichiometry of more than one Na cotransported per PO
 
4
 
. In K562
 
cells, external lithium activation of phosphate inﬂux was also cooperative. Inhibition by arsenate, 
 
K
 
I
 
 
 
5 
 
2.6–2.7
mM, and relative inhibition by amiloride, amiloride analogs, phosphonoformate, and phloretin were similar.
These characteristics were different from those reported for hNaPi-3 and hPiT-1 in other systems. PCR analysis of
sodium-phosphate cotransporter isoforms in K562 cells demonstrated the presence of mRNAs for hPiT-1, hPiT-2,
and hBNP-1. The mRNAs for hNaPi-10 and hNaPi-3, the other two known isoforms, were absent. Western analysis
of erythrocytes and K562 cells with isoform-speciﬁc antibodies detected the presence of only hBNP-1, an isoform
expressed in brain neurons and glia. The similarities in the kinetics and the expression of only hBNP-1 protein in
the two cell types is strong evidence that hBNP-1 is the erythrocyte and K562 cell sodium-phosphate cotransporter.
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INTRODUCTION
 
The kinetics of sodium-stimulated phosphate ﬂux and
phosphate-stimulated sodium ﬂux in human red cells
were initially described by Shoemaker et al. (1988). Re-
cently, we have shown that the Na-phosphate cotrans-
porter can also mediate Li-phosphate cotransport with
similar kinetics and pharmacology (S. Elmariah and R.B.
Gunn, manuscript in preparation). It is known that the
rabbit kidney Na-phosphate cotransporter (NaPi-2) can
mediate Na–Na exchange (Forster et al., 1998) and no
other examined isoform transports lithium. Thus, the
erythrocyte Na-phosphate cotransporter may mediate
both the ouabain-insensitive Na–Na exchange and Na–
Li exchange activities. The molecular identiﬁcation of
the Na–Li exchanger in erythrocytes and neurons has
important clinical implications for understanding the
treatment of bipolar disease with lithium and the devel-
opment of essential hypertension. Although more than
24 Na-phosphate cotransporters in three gene families
(Fig. 1) have been cloned and some are expressed in oo-
cytes (Werner et al., 1991; Magagnin et al., 1993) and
cultured mammalian cells (Quabius et al., 1996; Timmer
and Gunn, 1998), the molecular basis for the sodium–
phosphate cotransporter in erythrocytes is unknown.
Human representatives of each type have been cloned:
hNaPi-10, a type Ia; hBNP-1, a type Ib; hNaPi-3, a type
IIa; hPiT-1, a type IIIa; and hPiT-2, a type IIIb. Some of
these isoforms show very restricted expression; e.g., type
II cotransporters are principally found in the kidney and
small intestine. In contrast, the type III isoforms are
found in nearly every tissue in the body and thus are felt
to be the constitutive housekeeping forms of Na-phos-
phate cotransporters that every cell seems to require to
maintain intracellular phosphate above electrochemical
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equilibrium with respect to plasma phosphate. Because
most cells express several isoforms of Na-phosphate
cotransporters, the kinetics of individual isoforms have
been evaluated principally in brush border vesicles, oo-
cytes, and mammalian expression systems that may lack
native regulatory mechanisms. The type Ia isoform was
originally identiﬁed in proximal tubules of the kidney
(Werner et al., 1991). A type Ib Na-phosphate cotrans-
porter was recently cloned by subtractive hybridization
of 
 
N
 
-methyl-
 
d
 
-aspartate (NMDA)–treated primary cul-
tures of cerebellar granule cells isolated from rat pups
(Ni et al., 1994). This Na-phosphate cotransporter was
originally reported to be a brain speciﬁc Na-PO
 
4
 
–inor-
ganic cotransporter (BNPI or BNP-1), but the human
isoform was also detected by Northern analysis in intes-
tine, colon, and testes (Ni et al., 1996). Expression of
BNP-1 in oocytes increased Na-dependent 
 
32
 
PO
 
4
 
 uptake
(Ni et al., 1994). The amino acid sequences of hBNP-1
(Ni et al., 1996) and hNaPi-10 (Chong et al., 1993) share
22% identity, as determined using the ClustalX algo-
rithm for sequence alignment (Higgins et al., 1996). Any
of these or an unknown gene’s product could be respon-
sible for erythrocyte Na-PO
 
4
 
 cotransport.
K562 cells were ﬁrst isolated by Lozzio and Lozzio in
1971 from a patient with chronic mylogenous leukemia
in blast crisis (Lozzio and Lozzio, 1975). The cells have
many characteristics of a red cell precursor; e.g., they
can be stimulated to produce embryonic and fetal
hemoglobin after treatment with dimethylsulfoxide,
hemin, butarate, thymidine, etc. In addition, they con-
stitutively express many red cell proteins, including
spectrin and glycophorin A (Yurchenco and Furthmayr,
1980) and L-type pyruvate kinase (Jansen et al., 1983).
However, there are no previous reports regarding the
existence of a Na-phosphate cotransport system in
these cells or the identity of speciﬁc isoforms that may
be expressed. K562 cells may express any combination
of Na-PO
 
4
 
 cotransporter genes to feed their high meta-
bolic demand for phosphate. It is known that they do
not express AE1, which is the dominant phosphate
pathway in mature erythrocytes (Horton et al., 1981;
Law et al., 1983; Dissing et al., 1984), and thus the Na-
PO
 
4
 
 cotransporter present in erythrocytes (Shoemaker
et al., 1988) may be overexpressed to meet these needs.
Since mature human red blood cells are anucleated
and have no DNA or RNA, the identiﬁcation of the
gene of origin of a given protein is not always straight-
forward. We reasoned that if the kinetics of phosphate
transport in K562 cells paralleled those of the Na-acti-
vated pathway in erythrocytes and yet were distinct
from those known for other Na-PO
 
4
 
 cotransporters,
then the expressed genes may be the same in K562 cells
and mature erythrocytes. Furthermore, the identiﬁca-
tion of the mRNAs for Na-PO
 
4
 
 cotransporters in K562
cells would restrict the likely gene candidates, and con-
 
cordance of Western analysis on the two cell types
could speciﬁcally identify the transporter, provided its
known kinetic characteristics did not conﬂict with
those of the two cell types. In this paper, we show
that the transporter that mediates the Na-phosphate
cotransporter in K562 cells has the same kinetic and
pharmacological characteristics as the transporter re-
sponsible for Na-phosphate cotransport in mature hu-
man red cells. The characteristics of Na-dependent
 
32
 
PO
 
4
 
 inﬂux into K562 cells and red blood cells are
distinct from those of the renal sodium-phosphate
cotransporter, hNaPi-3, or a widely expressed Na-PO
 
4
 
cotransporter, hPiT-1. We demonstrate by reverse tran-
scription–PCR (RT-PCR)
 
1
 
 that the K562 cells contain
mRNA for hPiT-1, hPiT-2, and hBNP-1, but not hPiT-10
or hNaPi-3. We show by Western analysis using speciﬁc
antibodies to the individual cotransporters that hBNP-1
is the only Na-phosphate cotransporter polypeptide de-
tectable in K562 cells and human red cells. We con-
clude that the K562 cells have a Na-phosphate cotrans-
Figure 1. Dendrogram showing the three major families of Na-
phosphate cotransporters identiﬁed in mammalian cells. The mul-
tiple sequence alignment was carried out using ClustalX on the de-
rived amino acid sequences for the indicated isoforms (protein
weight matrix used was Dayhoff PAM 250; gap penalty, 10; and
ﬂoating gap penalty, 10; see Thompson et al., 1994). The dendro-
gram was constructed from the dendrogram output ﬁle of Clust-
alX. The commonly used designation for the given isoform is
given in parentheses next to the species type from which the
cDNA was isolated. The corresponding gene names for these iso-
forms as designated by the Human Gene Nomenclature Commit-
tee (HGNC) are as follows: (a) SLC17A1 for NaPi-10; (b)
SLC20A1 for hPiT1; (c) SLCS20A2 for hPiT2; and (d) SLC34A1
for NaPi-3. There is no name designated by HGNC for hBNP-1.
 
1
 
Abbreviations used in this paper:
 
 DNDS, 4,4
 
9
 
-dinitro-2,2
 
9
 
-stilbenedisul-
fonic acid; Hgb, hemoglobin; PCA, perchloric acid; pCMBS, 
 
p
 
-chlo-
romercuri phenylsulfonate; PFA, phosphonoformate; RT-PCR, re-
verse transcription–PCR. 
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porter that is the gene product of hBNP-1, and that this
transporter protein is the same as, or closely related to,
the one in mature human red cells.
No native cells have been used previously for the sepa-
rate study of PiT-1, PiT-2, or BNP-1. The transport char-
acteristics of these isoforms are wholly derived from
their expression in 
 
Xenopus
 
 oocytes (Kavanaugh et al.,
1994; Ni et al., 1994; Kavanaugh and Kabat, 1996), al-
though the expression of one isoform may dominate,
such as PiT-2 in rat ﬁbroblasts (Kavanaugh et al., 1994).
We propose here that erythrocytes and K562 cells are
model systems for the behavior of BNP-1 which is also
expressed in neuronal and glial cells, particularly the
amygdala and hippocampus. Erythrocytes and K562 cells
are the only cells known to express a single sodium-phos-
phate cotransporter isoform. The homologs of all three
isoforms are widely expressed in rat brain, possibly in the
same cells. The expression of rBNP-1 is selectively re-
duced in CA1 pyramidal neurons of the hippocampus,
after ischemia (Ni et al., 1997) and signiﬁcantly upregu-
lated in cerebellar granule neurons after subtoxic doses
of the excitatory amino acid NMDA (Ni et al., 1994).
The only Na-PO
 
4
 
 cotransport measurements in neurons
have been in cells whose compliment of sodium phos-
phate isoforms were not determined (Glinn et al., 1995).
Another possible reason for the importance of identi-
fying hBNP-1 as the erythrocyte Na-PO
 
4
 
 cotransporter
is the observation that lithium can substitute for Na on
the cotransporter. There are no other good molecular
candidates for the Na–Li exchanger in erythrocytes.
The strong arguments against the sodium–hydrogen
exchanger isoform (NHE1–NHE4) as the Na/Li ex-
changer are summarized by West et al. (1998). It has
been shown that the activity of the erythrocyte Na–Li
exchanger correlates with the therapeutic responsive-
ness of patients with bipolar (manic depressive) disease
to lithium therapy (Ostrow et al., 1978; Pandey et al.,
1984; Zaremba and Rybakowski, 1986), but this re-
mains controversial since it is not found in all patient
populations (Werstiuk et al., 1984). Similarly, the activ-
ity has been shown to correlate with the development
of essential hypertension (Canessa et al., 1980; Adragna
et al., 1982; Cooper et al., 1983; West et al., 1998). Con-
sequently, the activity of BNP-1 in erythrocytes may be a
marker for its activity in the brain and other tissues in-
accessible to diagnostic assays.
 
MATERIALS AND METHODS
 
Materials
 
K562 cells (CCL 243) were obtained from American Type Cul-
ture Collection. Fetal calf serum was obtained from Atlanta Bio-
logicals; RPMI 1640, 
 
l
 
-glutamine, and other media components
were obtained from Life Technologies, Inc. Disposable plastic
culture ﬂasks and dishes were obtained from Corning, Inc. All
chemicals were reagent grade or better, and were obtained from
 
either Fisher Scientiﬁc or Sigma-Aldrich. The sodium salt of 4,4
 
9
 
-
dinitro-2,2
 
9
 
-stilbenedisulfonic acid (DNDS) was obtained from
Pfaltz and Bauer, Inc. Reagents used in PCR and RT-PCR were
obtained from CLONTECH Laboratories, Inc. or PE Biosystems.
Isotopes were purchased from New England Nuclear. Optiﬂuor
scintillation ﬂuor was obtained from Packard Instrument Co.
 
K562 Cells
 
Cells were maintained and grown in suspension in RPMI 1640
media supplemented with 10% heat-inactivated fetal calf serum
containing penicillin (50 U/ml) and streptomycin (50
 
 
 
m
 
g/ml).
The cells were grown and incubated at 37
 
8
 
C in a 5% CO
 
2
 
 atmo-
sphere. The cells in all experiments were harvested and used
from suspensions in logarithmic growth phase after being seeded
at a density of 10
 
5
 
 cells/ml.
 
Flux in K562 Cells
 
Cells (6–7 
 
3
 
 10
 
8
 
) were harvested by decanting the cell suspension
into several 50-ml tubes and centrifuging them at 3,000 
 
g
 
 for 5
min at 4–10ºC. The clear media was aspirated, the cell pellets re-
suspended in wash media to a total volume of 
 
z
 
100 ml, and the
cell suspensions were combined. Wash media contained (mM):
0.81 MgCl
 
2
 
, 5.55 
 
d
 
-glucose, 0.3 KH
 
2
 
PO
 
4
 
, 25 HEPES, pH 7.64 at
20ºC. The cell suspensions were centrifuged brieﬂy at 3,000 
 
g
 
, the
supernatant was aspirated, and the cell pellets were resuspended
in wash media. This cell washing procedure was repeated three
times. After the last centrifugation step, the cells were resus-
pended in a minimal volume of wash medium (8–10 ml) by gen-
tle vortexing to form a markedly concentrated cell suspension
(
 
z
 
7 
 
3 
 
10
 
7
 
 cells/ml) that was held at 20
 
8
 
C until use (
 
,
 
15 min).
The sodium-dependent 
 
32
 
PO
 
4
 
 inﬂux was calculated as the differ-
ence between the inﬂux measured in the presence and absence of
sodium. The inﬂux media contained (mM): 4.36 KCl, 0.81 MgCl
 
2
 
,
5.55 
 
d
 
-glucose, 25 HEPES, and either 143.5 NaCl titrated with
NaOH or 143.5 NMDG titrated with HCl to pH 7.64 at 20–21
 
8
 
C.
Stoppered Erlenmeyer ﬂasks (50 ml) contained 10 or 15 ml of a me-
dium with a prescribed composition and 1–2 
 
m
 
Ci/ml of 
 
32
 
PO
 
4
 
. The
ﬂasks were placed in a shaking water bath at 37
 
8
 
C. After tempera-
ture equilibration of the media, the 
 
32
 
PO
 
4
 
 inﬂux measurements
were initiated by adding 
 
z
 
1 ml of the concentrated cell suspension
prepared as described above. This addition dilutes the medium Na
to 
 
z
 
130 mM during the ﬂux measurement. Duplicate samples were
taken at known times (
 
z
 
1, 2, 4, 7, 20, and 30 min) by removing 1-ml
samples from the ﬂasks and transferring them to labeled, 13-ml
polystyrene test tubes containing 5 ml of ice-cold stop solution. Stop
solution contained (mM): 144.5 NaCl, 6 KH
 
2
 
AsO
 
4
 
, 1 KH
 
2
 
PO
 
4
 
, and
20 HEPES, pH 7.64 at room temperature with KOH. These tubes
were placed in a refrigerated centrifuge and spun at 2,000–3,000 
 
g
 
for 3–4 min. The supernatant was aspirated, and the pellets were im-
mediately washed a further two times with 5 ml of ice-cold stop solu-
tion. The K562 cell pellets were lysed by addition of 250 
 
m
 
l of lysis so-
lution A (1 mM MgCl
 
2
 
, 20 HEPES, 0.5 Triton X-100, pH 7.6 at room
temperature), followed by incubation overnight at room tempera-
ture or for 2 h at 37
 
8
 
C. Next, 500 
 
m
 
l of lysis solution B (1% sodium
deoxycholate) was added, mixed by vortexing, and diluted by addi-
tion of 750 
 
m
 
l of glass distilled water to yield 1.5 ml lysate for each
sample. After the last timed sample was taken, the remaining cell
suspension in each Erlenmeyer ﬂask was transferred to a test tube,
centrifuged, and the clear supernatant was saved for analysis of
 
32
 
PO
 
4
 
, inorganic phosphate, and sodium. The lysed pellets of K562
cells were each analyzed for 
 
32
 
PO
 
4
 
 and protein. The radioactivity of
the lysate (0.5 ml) was counted in duplicate in Optiﬂuor (3 ml).
The protein was measured in duplicate using 100-
 
m
 
l samples in a
standard BCA protein assay (Smith et al., 1985) using bovine serum 
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albumin as a standard. The reaction was performed in microtiter
plates and measured in an MRX plate reader (Dynex Technologies)
at 570 nm, as previously described (Timmer and Gunn, 1998). The
radioactivity of the inﬂux solution was measured by counting 10 
 
m
 
l
of the ﬂux suspension supernatant together with 490 
 
m
 
l of a mixture
of the Triton X-100 and deoxycholate lysis solutions. The phosphate
concentration of the inﬂux solution was measured using a standard
malachite green method (Henkel et al., 1988; Timmer and Gunn,
1998). The samples for inﬂux solution–speciﬁc activity and cell lysis
samples were counted contemporaneously and no correction
(
 
,
 
0.5%) for radioactive decay was made.
 
Flux into Red Blood Cells
 
Human red blood cells were taken by venepuncture from one of
us (R.B. Gunn) into a heparinized graduated cylinder. The
whole blood was centrifuged in a 50-ml centrifuge tube at 12,000 
 
g
 
for 5 min at 4–10
 
8
 
C. The plasma and buffy coat were aspirated
before the red cell pellet was dispersed with a glass rod into three
volumes of ice-cold isotonic MgCl
 
2
 
 (110 mM) and again centri-
fuged brieﬂy at 12,000 
 
g
 
. This wash procedure was repeated two
to three more times and the mixed cells held on ice at 90% he-
matocrit until the ﬂux measurement was initiated (
 
,
 
2 h).
The sodium-dependent 
 
32
 
PO
 
4
 
 ﬂux into erythrocytes was mea-
sured in the same way as into K562 cells using the same ﬂux medium
with the following exceptions: (a) the inﬂux media contained 0.25
mM DNDS, to block AE1-mediated phosphate inﬂux; (b) samples
were usually taken at 
 
z
 
15, 45, and 75 min; and (c) at the end of the
washings, the red cells were lysed by adding 1 ml of glass-distilled
H
 
2
 
O and vortexing. The lysed red blood cell pellets were each ana-
lyzed by: (a) transferring 50 
 
m
 
l into 5-ml test tubes with 2 ml of mod-
iﬁed Drabkin’s solution, vortexing the test tube, and reading the
concentration of cyanmethemoglobin at 540 nM in a Novaspec II
spectrophotometer (Amersham Pharmacia Biotech) (the product of
the OD
 
540
 
, the dilution in Drabkin’s solution, and the factor 1.465
was used to calculate the milligrams of hemoglobin per milliliter in
the lysate); and (b) taking 500 
 
m
 
l of each lysate into a 2-ml microcen-
trifuge tube with 250 
 
m
 
l of 7% (vol/vol) perchloric acid (PCA). After
vortexing and a brief centrifugation of the tubes, 350 
 
m
 
l of the clear
supernatant was counted with 3 ml of Optiﬂuor in a Tricarb-4000 liq-
uid scintillation counter (Packard Instrument Co.). The radioactivity
of the inﬂux solution was measured by counting either 10 
 
m
 
l of the
ﬂux suspension supernatant together with 340 
 
m
 
l of 2% PCA or mea-
suring 350 
 
m
 
l of a PCA extract of the supernatant prepared in the
same way as the red cell lysate samples. In Na
 
1
 
-free media, choline
 
2
 
-
DNDS was used. It was prepared by ion exchange of Na
 
2
 
DNDS on a
choline column of Rexyn 101 (H) (Fisher Scientiﬁc).
 
Flux Analysis
 
The values of picomoles per microgram protein for each of the
six or more samples were plotted against the time elapsed be-
tween initiation of the inﬂux and the time at which the samples
were added to the ice-cold arsenate (K562 cells) or MgCl
 
2
 
 (red
cells) solution to stop the inﬂux reaction. The time course of
 
32
 
PO
 
4
 
 content of K562 cells in a typical experiment is shown in
Fig. 2. The 12–16 data points were ﬁt to an exponential equation:
 
y
 
(
 
t
 
) 
 
5 
 
y
 
inﬁnity *[1 2 exp(2kt)], where y is the cell content in pico-
moles per microgram protein at time t. The cell content of phos-
phate was determined from the ratio of the tracer content of the
cells and the speciﬁc activity of the medium. The steady state
content of the cells was estimated by the best-ﬁt value to yinﬁnity.
The initial inﬂux rate is given by the initial slope of the graph
and is equal to the product of the two best-ﬁt parameters: yinﬁnity
and k. In Fig. 2, the ﬂux in a high sodium medium was 1,800
nmol/(g protein ? min). The activation curves for phosphate
were ﬁt by minimization of the sum of squares for the Michaelis-
Menten equation: v 5 Vmax PO4/( 1 PO4), where V is the
ﬂux, PO4 is the extracellular total phosphate concentration
(mM), and   is the concentration of total extracellular
phosphate that causes half-maximal 32PO4 inﬂux. The minimiza-
tion algorithm used was the Solver module in the Excel spread-
sheet (Microsoft Corp.). The activation curves for sodium were
ﬁt using the Hill equation: Flux 5 h[Na]o
n/(1 1 h[Na]o
N), where
h is the Hill constant and N is the Hill coefﬁcient.
Water Content
The water content of the red cells and K562 cells were measured.
Red cells or K562 cells washed in appropriate media were loaded
in nylon tubes at z50–70% cytocrit and packed under standard
centrifugation conditions (Gunn et al., 1973). The grams of cell
water content was measured by drying to constant weight at 958C,
a known weight of wet packed cells and correcting for 2.5% (wt/
wt) trapped extracellular space in red cells and 8–20% (wt/wt)
trapped extracellular space between the K562 cells. The trapped
space was measured using 14C-polyethylene glycol or H3-inulin
under the same packing conditions.
Ion Content
The ion contents of K562 cells were determined by making extracts
of known weights of wet packed cells in 7% (vol/vol) PCA and
measuring the Na and K concentration by atomic emission spec-
troscopy, the chloride concentration by coulombometric titration,
and the phosphate concentration as described above. The ion con-
tents of K562 cells were measured after washing in either RPMI,
110 mM MgCl2, the NMDG-Cl or NaCl solutions given above.
Antibody Production
Peptides were synthesized and puriﬁed by reversed-phase HPLC
(Emory University Microchemical Facility). The peptides that were
synthesized are as follows: (a) the hPiT-1–speciﬁc peptide was
CEERTVSFKLGDLEEAPERER, (b) the hPiT-2-speciﬁc peptide was
K12 ¤
PO4
K12 ¤
PO4
Figure 2. Typical time course of phosphate inﬂux in K562 cells
in the presence and absence of Nao. Time course of traced phos-
phate content into K562 cells. (Top) 32PO4 inﬂux into K562 cells
in 128 mM NaCl medium. (Bottom) 32PO4 inﬂux into K562 cells in
the absence of Na (150 N-methyl-d-glucamine medium), pH 7.4,
37ºC, 0.3 mM PO4. The cell content of traced phosphate as a func-
tion of time was a single exponential y(t) 2 yo 5 (y` 2 yo) ? (1 2
e2kt) where yo is the extrapolated initial traced content, y` is the
steady state traced content, and the initial slope of the curve is the
inﬂux: (y¥ 2 yo) ? (k) 5 1,800 6 570 nmol/(g protein ? min). Du-
plicate values are obscured by the symbols.367 Timmer and Gunn
CNAVAEAEIEAEEGGVEMKLASE, and (c) the hBNP-1–speciﬁc
peptide was CYESPALHPSISEEERKYIED. The N-terminal cysteine
residue is not present in the target isoform polypeptide sequence
and was added to facilitate conjugation to keyhole limpet hemocy-
anin (KLH; Pierce Chemical Co.) with sulfosuccinimidyl 4-[N-
maleimidomethyl]cyclohexane-1-carboyxlate (sulfo-SMCC; Pierce
Chemical Co.). In brief, 2.0 ml KLH (10 mg/ml in water) was ﬁrst
activated by adding 1.0 ml of sulfo-SMCC (4.6 mM or 2 mg/ml)
dissolved in conjugation buffer (83 mM Na2HPO4, 900 mM NaCl,
and 100 mM EDTA). The activation reaction of KLH and sulfo-
SMCC was allowed to proceed for 1 h at room temperature (18–
22ºC). The unreacted sulfo-SMCC is removed from KLH and sulfo-
SMCC-activated KLH by gel ﬁltration column chromatography.
The reaction mixture was applied to a 10-ml column (EconoPac
10DG column; BioRad, Inc.) equilibrated with conjugation buffer
and fractions (2.5 ml) collected. The protein concentration in
each fraction was determined and the fractions containing the pro-
tein peak were pooled. The activated protein (sulfo-SMCC–acti-
vated KLH) was incubated with 10 mg of the peptide dissolved in
2.5 ml of conjugation buffer. The conjugation reaction was allowed
to proceed for 2 h at room temperature, and then dialyzed over-
night at 4ºC against 500 ml phosphate-buffered saline (1.76 mM
KH2PO4, 8.05 mM Na2HPO4, 136 mM NaCl, and 2.68 mM KCl, pH
7.2). The ﬁnal solution contained the peptide-KLH in PBS (z0.4
mg peptide/ml and 1.7 mg KLH/ml). The peptide conjugate (100
ml at 0.8–0.9 mg/ml in PBS) was emulsiﬁed with Titermax (250 ml;
CytRx Corp.) using a syringe according to the manufacturer’s in-
structions. The emulsiﬁed conjugate adjuvant (50 ml) was injected
in each hind quadricep of New Zealand White rabbits. At week
ﬁve, a second injection of conjugate adjuvant was carried out as de-
scribed above. Positive antisera were obtained by week three. Injec-
tions were carried out and antisera were obtained according to
standard protocols at Lampire Biological Laboratories. Control
sera were obtained from the same rabbits before the ﬁrst injection.
Western Analysis
We followed the detailed protocol previously published (Timmer
and Gunn, 1998), except that protein was transferred to PVDF
(polyvinylidene diﬂuoride) membranes instead of nitrocellulose
membranes. The concentration of protein in the cell lysates was
determined by the BCA method, as described above. Blots were
probed with the primary antibody directed against the indicated
Na-PO4 cotransporter protein isoforms, then developed using
goat anti–rabbit immunoglobulin conjugated to horseradish per-
oxidase and chemiluminescence according to the manufacturer’s
protocol (ECL Western Blot kit; Amersham Pharmacia Biotech).
The primary antibodies used in these studies were prepared as
described above (anti–PiT-1, anti–PiT-2, and anti–BNP-1) or as
previously described (anti–NaPi-3; Timmer and Gunn, 1998).
RT-PCR Reaction and Analysis
PCR reactions were carried out on cDNA using the Advantage 2
PCR enzyme system (CLONTECH Laboratories, Inc.). This en-
zyme system contains a mixture of a recombinant engineered Taq
polymerase, a proofreading thermophilic DNA polymerase, and an
antibody to the Taq polymerase to enable “hot start” PCR reactions.
Thermocycling conditions were as follows: 1 cycle at 95ºC for 1
min; 30 cycles of 30 s at 95ºC and 3 min at 68ºC; and then the reac-
tion was held at 25ºC for 1–8 h. The primer concentration used in
these reactions was 0.4 mM, and all other reaction conditions were
as suggested by the manufacturer. The cDNA used in the reactions
was obtained from CLONTECH Laboratories, Inc. Control PCR
reactions used primers speciﬁc for GAPDH. The GAPDH primer
sequences used are as follows: (a) GAPDH-F, (59) ACC ACA GTC
CAT GCC ATC AC (39); and, (b) GAPDH-R, (59) TCC ACC ACC
CTG TTG CTG TA (39). The expected product from the GAPDH
primers is 452 bp. The isoform-speciﬁc primers were designed with
the aid of computer software (Primer Designer; Scientiﬁc and Edu-
cational Software). The primer pairs with sequences, target iso-
form, and expected PCR product size are shown in Table I.
RESULTS
Phosphate Activation
The   for phosphate activation of 32PO4 inﬂux
into K562 cells was determined from ﬂux measure-
K12 ¤
PO4
TABLE I
Primers Used for RT-PCR Analysis of Isoform Expression
Target
isoform*
Forward 
primer
Reverse 
primer
Forward primer 
sequence‡
Reverse primer 
sequence‡
Expected
product
bp
hPiT-1 Pit1-1451F Pit1-2275R
CAG TTC AGT CCA
GCC GTC AG
CCA GCC AAC AGA
CAC AAC AG 825
hPiT-1 Pit1-1882F Pit1-2191R
TGA CCA GGA TAA
GCC TGA AG
GGC AGA TGC CAG
TTC AAT AC 310
hPiT-2 Pit2-482F Pit2-1416R
ACA ACG AGA CGG
TGC TCA TC
CAC ACT TCT CCT
CGC TCA TC 935
hBNP-1 BNP-1410F BNP-1875R
CGT TCT ACC TGC
TGC TCA TC
CAC ACT TCT CCT
CGC TCA TC 466
hBNP-1 BNP-1410F BNP-1985R
CGT TCT ACC TGC
TGC TCA TC
AAC ACG TAC TGC
CAC TCC TC 576
NaPi-10 NP10-512F NP10-970R
GAG GCC GAC TTA
CTT CTA TGA G
GAC CTG CTA GGT
TAC CAC AGA T 459
NaPi-10 NP10-267F NP10-971R
TTC CAC CTC CTA
TGG TGT CAT C
TGA CCT GCT AGG
TTA CCA CAG A 705
NaPi-3 NP03-952F NP03-1430R
AGT CTC ATY CRG
ATY TGG TG
GGC CAG KGC WGC
CAG GAT 479
*The Genbank accession numbers for the target isoforms are as follows: hPiT-1, NM_005415; hPiT-2, NM_006749; hBNP-1, I73260; NaPi-10, NM_005074;
and NaPi-3, NM_003052. ‡IUPAC symbols are used for nucleotides and degenerate nucleotides. 368 Molecular Basis of Na-PO4 Cotransport in Erythrocytes
ments at several different total phosphate concentra-
tions in sodium media at pH 7.4 at 378C (Fig. 3). The
K1/2 5 0.36 mM when ﬁt to the Michaelis-Menten equa-
tion by weighted least squares analysis. For comparison,
we previously reported that the K1/2 for 32PO4 ﬂux into
human erythrocytes was 0.30 6 0.02 mM under similar
conditions (Shoemaker et al., 1988).
Selectivity of Monovalent Cation Activation
Activation of the 32PO4 inﬂux by monovalent cations is
shown in Fig. 4 for K562 cells. Chloride media with the
only monovalent cation being 143 mM N-methyl-d-glu-
camine, choline, rubidium, potassium, or cesium gave
small or negligible 32PO4 inﬂuxes into K562 cells. Only
lithium and sodium were able to activate the ﬂux rela-
tive to the other cations. The activation of the 32PO4 in-
ﬂux in K562 cells (Fig. 4) by 143 mM external lithium
was 19% (66%, n 5 15) of the activation by 143 mM
external sodium (100%). This relative activation by
these two alkali cations was the same in erythrocytes (S.
Elmariah and R.B. Gunn, manuscript in preparation)
and was much greater than the relative activation
(,2%) reported in HEK-293 cells expressing hNaPi-3
(Timmer and Gunn, 1998) or seen in oocytes express-
ing hPiT-1 (Olah et al., 1994).
Sodium Activation
The concentration dependence for external sodium ac-
tivation of 32PO4 inﬂux in both K562 cells and human
erythrocytes is shown in Fig. 5. In both cases, the sodium
concentration was adjusted by isomolar substitution with
NMDG. In both cell types, the cooperative activation by
Na is evident by the sigmoidicity of the activation graph.
This is consistent with more than one Na1 ion being re-
quired for phosphate inﬂux. Although this cooperativity
has not been previously reported in erythrocytes, it is
consistent with the previous measurements of the sto-
ichiometry showing that more than one sodium is trans-
ported for each phosphate transported (Shoemaker et
al., 1988). In K562 cells the K1/2
Na was 34 mM with Hill
coefﬁcient n 5 1.5 and the constant h 5 0.0047. How-
ever, these data can be equally well ﬁt [nearly the same
sum of squares of residuals: 886,797 (Hill) vs. 968,855
(M–M)] by a Michaelis-Menten equation (n 5 1.0) with
best ﬁt parameters for K1/2
Na 5 80 mM and for Vmax 5
6,000 nmol/(g protein · min). In erythrocytes, the K1/2
Na
was 46 mM, n 5 1.9, and h 5 0.00058.
Lithium Activation
The graph of the activation of 32PO4 inﬂux by external
lithium was also cooperative in K562 cells (Fig. 6) and
in erythrocytes (S. Elmariah and R.B. Gunn, manu-
script in preparation). This suggests that there are at
least two sites for lithium on the extracellular domain
of the transporter that must be occupied by lithium for
transport of phosphate in the absence of extracellular
Na. Although the K1/2
Li was .140 mM Li in sodium-
free media (Fig. 6, K1/2
Li z 400–500 mM), the extrapo-
lated maximum ﬂux was about the same for Li as for
Na activation under the same conditions [3,900 nmol
PO4/(g protein ? min)]. If the two cation binding sites
for Na and Li are the same two sites, then the apparent
afﬁnity of the lower afﬁnity site is greater for sodium
than for lithium. This follows from using the reciprocal
of the K1/2 values as a measure of the apparent afﬁnity
of the second (lower afﬁnity) cation activation site.
Namely, (34 mM; Na,K562)21 > (46 mM; Na,RBC)21
.. (z450 mM; Li,K562)21. This lower afﬁnity for Li in
the context of comparable Vmax values for the phos-
phate ﬂux activated by either cation appears to be the
sole reason why 143 mM Li only activates 19% as well as
143 mM Na1.
The activation of 32PO4 inﬂux at low concentrations
(0–30 mM) of lithium (Fig. 6, bottom) did not appear
to be cooperative upon careful inspection in two exper-
iments, but rather could be ﬁt with a Michaelis-Menten
equation using K1/2
Li  > 7 mM and Vmax > 90 nmol
PO4/(g protein ? min). This component could be sub-
tracted from the total ﬂux to reveal the cooperative
component as shown by the dotted curves in Fig. 6.
Arsenate Inhibition
Phosphate transport in the dog kidney (Ginsburg and
Lotspeich, 1962), rat kidney brush border membrane
vesicles (Hoffmann et al., 1976), and gut (Berner et al.,
1976) is inhibited by arsenate, which behaves as a phos-
Figure 3. Determination of the K1/2 for phosphate activation of
32PO4 inﬂux. Extracellular phosphate activation of 32PO4 ﬂux into
K562 cells at Naout 5 130 mM. The data were ﬁt to the Michaelis-
Menten equation, v 5 Vmax ? [PO4]out/(K1/2 1 [PO4]out), by non-
linear least squares. For the data shown, Vmax 5 4,630 nmol PO4/
(g protein ? min) and K1/2 5 0.36 mM. The phosphate inﬂux was
almost entirely Na dependent: the ﬂux carried out at 0.3 mM PO4
in the absence of Na1 was only z75 nmol PO4/(g protein ? min).
Each point is a single ﬂux calculated from the time course of six
values at the given extracellular phosphate concentration. One of
ﬁve similar experiments.369 Timmer and Gunn
phate congener (Gmaj and Murer, 1986; Kenney and
Kaplan, 1988). Arsenate inhibits sodium-activated
32PO4 inﬂux into erythrocytes (S. Elmariah and R.B.
Gunn, manuscript in preparation) with a Ki 5 2.6 mM
assuming complete competitive inhibition. Arsenate in-
hibits 32PO4 inﬂux into K562 cells (Fig. 7) with a Ki 5
2.7 mM. These values are in contrast to the Ki 5 0.4
mM reported for the inhibition of hNaPi-3 expressed
in HEK-293 cells (Timmer and Gunn, 1998).
Pharmacology of Inhibition
In addition to the kinetics of activation, the pharmacol-
ogy of inhibition, or lack thereof, is the same in mature
erythrocytes and K562 cells measured under the same
conditions. Shown in Fig. 8 is a comparison of the inhi-
bition of 32PO4 inﬂux by amiloride and six amiloride
analogs in the two cell types. There are some minor
variations between the two cell types, but, in general,
amiloride and its analogs are poor inhibitors of the Na-
dependent ﬂux in these two cell types. Thus, the
amiloride binding sites or its ability to inhibit this Na-
PO4 cotransporter are different from that on the Na/H
and Na/Ca exchangers (Kleyman and Cragoe, 1988),
epithelial Na channels of the principal cells of the dis-
tal nephron (Kleyman and Cragoe, 1988), the Na-hex-
ose (Cook et al., 1987), or the Na-alanine (Harris et al.,
1985) cotransporters, which are all amiloride sensitive
and over 90% inhibited at these concentrations. Re-
sults in Fig. 9 show the percent of the control Na-phos-
phate ﬂux into K562 cells and erythrocytes after treat-
ment with p-chloromercuri phenylsulfonate (pCMBS),
phosphonoformate (PFA), phloretin, vanadate, and
DNDS. The effect of these drugs on NaPi-3–mediated
Na-phosphate cotransport has been reported (Timmer
and Gunn, 1998). There is only an apparent difference
in the inhibition by pCMBS in erythrocytes and K562
cells. This is probably due to the high concentration of
glutathione (1 mM) in red cells but not K562 cells since
glutathione reacts with pCMBS and reduces the effec-
tive concentration in the erythrocyte experiments. In
erythrocytes, the sensitivity of the cotransporter to
DNDS cannot be directly determined since it was al-
ways present in the assays to block the AE1-mediated
phosphate ﬂux. However, since the Na-activated por-
tion of the phosphate ﬂux was always the same in the
absence or presence of DNDS, the Na-phosphate cotrans-
porter is not believed to be inhibited by DNDS. PFA has
little effect on the Na-activated phosphate transport
into K562 cells or erythrocytes, but is a strong inhibitor
of NaPi-3 (Timmer and Gunn, 1998).
Figure 4. Activation of 32PO4 inﬂux by monovalent cations in
erythrocytes and K562 cells. Monovalent cation activation of 32PO4
inﬂux in the presence of 1.0 mM external phosphate, pH 7.4,
37ºC, and ﬂuxes were carried out as described with each indicated
cation present at 143 mM using the chloride salt. The standard er-
rors of six determinations in one of four similar experiments.
Figure 5. Determination of the K1/2 for sodium activation of
32PO4 inﬂux. Sodium activation of 32PO4 ﬂux into erythrocytes
(top) and K562 cells (bottom) was determined. In these experi-
ments, the total phosphate concentration was 0.3 mM. Both curves
appear sigmoidal, although the data from K562 cells is equally well
ﬁt by a single site (Michaelis-Menten) equation. Using the Hill
equation, the concentration of sodium required for half maximal
activation of phosphate inﬂux was 46 mM for erythrocytes and 34
mM for K562 cells. The extrapolated maximum ﬂux was 277
mmol/[kg hemoglobin (Hgb) ? h] in erythrocytes and 3,900
nmol/(g protein ? min) in K562 cells. The Hill coefﬁcient, N, was
1.9 for erythrocytes and 1.5 for K562 cells. When the Michaelis-
Menten equation was used to ﬁt the data from K562 cells, the Vmax
was 6,000 nmol/(g protein ? min) and K1/2 5 80 mM.370 Molecular Basis of Na-PO4 Cotransport in Erythrocytes
These data show that the kinetic and pharmacologi-
cal characteristics of the Na- and Li-activated 32PO4 in-
ﬂux is the same in K562 cells and mature erythrocytes.
These kinetics are very different from the renal trans-
port mechanisms mediated by hNaPi-3 (NaPi-2, rat).
This is most easily explained by a common molecular
mechanism in K562 cells and erythrocytes and one that
is different from that in renal cells. We have, therefore,
determined which genes of known sodium-phosphate
cotransporter proteins are expressing mRNA in the
K562 cells, and thus which protein was probably re-
sponsible for these ﬂux characteristics.
PCR Analysis of Sodium-Phosphate Cotransporter Isoforms
We used primer design software to design several sets of
primers speciﬁc for the human forms of the major
known Na-dependent phosphate transporters shown in
the dendrogram in Fig. 1. The primers used in these ex-
periments are described in Table I. PCR reactions were
carried out using cDNA templates (Fig. 10) derived from
speciﬁc human tissues (brain, liver, and kidney) and
K562 cells. The cDNA from human tissues was used as a
positive control for these primer sets; e.g., liver cDNA
was a positive control for the hPiT-1 and hPiT-2 primer
sets, brain cDNA was a positive control for the BNP-1
primer sets, and kidney cDNA was a positive control for
the NaPi-3 and NaPi-10 primer sets. It has been previ-
ously reported that PiT-1 and PiT-2 mRNAs are ubiqui-
tously expressed as determined by Northern analysis
(Kavanaugh et al., 1994). The expression of the two iso-
forms is approximately equal in liver (Kavanaugh and
Kabat, 1996), where there is Na-dependent, arsenate-
sensitive phosphate transport (Escoubet et al., 1993;
Ghishan et al., 1993; Younus and Butterworth, 1993). The
expression of BNP-1 mRNA was originally described as
being restricted to the brain (Ni et al., 1994). The high-
est level of expression of BNP-1 in human is in brain, al-
though there is low-level expression in intestine, colon,
and testes (Ni et al., 1996). The expression of NaPi-3, a
type IIa isoform, is restricted to the renal proximal tu-
bule (Magagnin et al., 1993). The principal tissue of ex-
pression for the type Ia isoform (e.g., NaPi-10) is also the
kidney (Chong et al., 1993). PCR carried out using these
Figure 6. Determination of the K1/2 for lithium activation of
32PO4 inﬂux in K562 cells. In these experiments, the total external
phosphate concentration was 0.3 mM. When the data over the en-
tire concentration range (0–143.5 mM Li1) are ﬁt to the Hill equa-
tion (top and bottom, solid line), the activation was cooperative
with K1/2
Li 5 430 mM and Hill coefﬁcient, N 5 1.7 for the best ﬁt
line as shown assuming Vmax 5 3,900 nmol PO4/(g protein ?
min). However, when the data at low lithium concentration (0–30
mM) are ﬁt to the Hill equation (bottom, dashed line), the activa-
tion was not cooperative with K1/2
Li 5 7 mM and Hill coefﬁcient,
N 5 1.0 for the best ﬁt line, as shown assuming Vmax 5 90 nmol
PO4/(g protein ? min). When the values from this line are sub-
tracted from the original data, and the resulting values ﬁt to the
Hill equation (top and bottom, dotted line), the activation was co-
operative with K1/2
Li 5 270 mM and Hill coefﬁcient, N 5 2.1 for
the best ﬁt line as shown assuming Vmax 5 2,100 nmol PO4/(g pro-
tein ? min). It appears that the activation of 32PO4 inﬂux has two
components: a hyperbolic component with a Hill coefﬁcient of 1
(cotransport of 1 Li1 and 1 PO4) and a sigmoidal component with
a Hill coefﬁcient of 2 (cotransport of two Li1 and one PO4).
Figure 7. Determination of the KI for arsenate inhibition of the
sodium-activated 32PO4 inﬂux in K562 cells. The data were ﬁt to the
equation for a competitive inhibitor: inﬂux 5 Vmax ? [PO4]/{K1/2 ?
(1 1 [arsenate]/Ki 1 [PO4])} by varying Ki. The constants were
used from Fig. 2: Vmax 5 3,712, K1/2 5 0.36 mM, [PO4] 5 0.3 mM.
The Ki value is 2.7 mM. The error bars are obscured by the symbols.371 Timmer and Gunn
primer sets speciﬁcally ampliﬁes the predicted products
from the cDNA prepared from tissues that are known to
express these isoforms (compare predicted product sizes
in Table I and the results in Fig. 10, left, A–H). When
cDNA prepared from K562 cells is used as the template
in the PCR reactions, only the primer sets for PiT-1, PiT-2,
and BNP-1 yield the expected products (Fig. 10, right,
D–H). In contrast, the primer sets for NaPi-3 and NaPi-
10 do not yield any products from the same template
cDNA. Thus, the mRNAs for PiT-1, PiT-2, and BNP-1 ap-
pear to be expressed in K562 cells. Similar results were
obtained using total RNA isolated from the K562 cells
used in these experiments and a single-tube RT–PCR sys-
tem (data not shown). All experiments were carried out
using a minus template negative control (water substitu-
tion for cDNA template). In these samples, there was no
visible bands produced, indicating the absence of con-
taminating DNA in the PCR reagents (data not shown).
GAPDH primers spanning a known intron indicate the
samples were not contaminated by genomic DNA; i.e.,
products of distinct size were realized with ampliﬁcation
from cDNA versus genomic DNA (data not shown).
Western Analysis of Sodium-Phosphate Cotransporter Isoforms
The expression of a particular mRNA does not always
mean that the corresponding protein is also expressed.
To determine whether the polypeptides for PiT-1, PiT-2,
and BNP-1 were expressed in K562 cells, it was necessary
to carry out Western analysis on total cell lysates. We had
previously prepared antibodies speciﬁc for NaPi-3, which
is a type II sodium-phosphate cotransporter (Fig. 1) that
is localized exclusively to the kidney (Timmer and Gunn,
1998). The other known human sodium-phosphate co-
transporters are: (a) NaPi-10, the human type Ia sodium-
phosphate cotransporter, which is found predominantly
in the kidney; (b) hBNP-1, the human type Ib cotrans-
porter that was originally localized to brain tissue; (c) the
hPiT-1 cotransporter; and (d) hPiT-2, which is homolo-
gous to hPiT-1, but is a distinct isoform.
Based on the isoforms detected by RT-PCR, we pre-
pared isoform-speciﬁc antipeptide polyclonal antibodies
to the hBNP-1, hPiT-1, and hPiT-2 cotransporter iso-
forms. To prepare these polyclonal antibodies, we fol-
lowed a ﬁve-step procedure to construct the peptide an-
tigens for the several sodium-phosphate cotransporters.
First, the sequence for each isoform was analyzed using
three different algorithms for prediction of membrane
protein topology (Kyte and Doolittle, 1982; Eisenberg et
al., 1984; Mohana Rao and Argos, 1986) to develop an
approximate picture of the number and location of
membrane-spanning segments for each. Second, the se-
quence was compared against the PROSITE database
(Bairoch et al., 1997) of protein motifs to determine the
location of potential sites for post-translational modiﬁca-
tion (e.g., glycosylation or phosphorylation). Third, the
known sequences for each type from several species
Figure 8. Comparison of the sensitivity of erythrocytes and K562
cells to inhibition by amiloride and its analogs. The ﬂux assays
were carried out as described, except that the media contained 0.3
mM total phosphate and 32.5 mM DMSO. The control (100%)
ﬂux values for erythrocytes were 0.26–0.30 mmol PO4/kg Hgb ? h
in different experiments. The control ﬂux values for K562 cells
were 850–960 nmol/g protein ? min. The standard deviation of
two to four determinations is shown by the error bars. Each of the
indicated compounds was used at 0.1 mM ﬁnal concentration. The
compounds used are indicated using their abbreviated names,
which are used for the following chemical names: Phenamil is phe-
namil methanesulfonate; DMA is 5-(N,N-dimethyl)-amiloride;
EIPA is 5-(N-ethyl-N-isopropyl)-amiloride; HMA is 5-(N,N-hexame-
thylene)-amiloride; and, MIA is 5-(N-methyl-N-isobutyl)-amiloride.
Figure 9. Pharmacology of inhibition of phosphate inﬂux in
erythrocytes and K562 cells. Various compounds were tested for
their ability to inhibit the Na-dependent phosphate inﬂux in hu-
man erythrocytes (shaded bars) or K562 cells (cross-hatched bars).
All erythrocyte suspensions also contained 0.25 mM DNDS to
block AE1. The control (100%) ﬂux values for erythrocytes were
0.20–0.41 mmol PO4/kg Hgb ? h in different experiments. The
control ﬂux values for K562 cells were 750–1,940 nmol/g protein ?
min. The standard deviation of two to four measurements is shown
by the error bars. Each of the indicated compounds was used at the
indicated concentrations. The following compounds were tested:
pCMBS, PFA, phloretin, sodium vanadate (vanadate), and DNDS.372 Molecular Basis of Na-PO4 Cotransport in Erythrocytes
were aligned using the Clustal algorithm (Higgins et al.,
1992) to deﬁne regions of homology between several
species to maximize the utility of the antisera. Fourth,
the sequences for hNaPi-10, hBNP-1, hPiT-1, and hPiT-2
using the Clustal algorithm (Higgins et al., 1992) to de-
ﬁne regions that are distinct for each of these cotrans-
porters. Finally, we analyzed the sequence using the al-
gorithm of Hopp and Woods (1981) to identify regions
with a high probability for eliciting an immune re-
sponse. The peptides that we used to make polyclonal
antibodies based upon these analyses are given in Table
II. Each immunizing peptide has a unique sequence
with minimal potential for post-translational modiﬁca-
tion; e.g., glycosylation or phosphorylation. We were un-
able to identify a single peptide sequence for either
hBNP-1 or hPiT-2 that would both be highly antigenic
and recognize human and rat isoforms. Therefore, we
used a peptide sequence that had lower predicted anti-
genicity but was common to both rat and human.
The antigens were prepared by conjugating the iso-
form-speciﬁc peptide to KLH, and the resulting antisera
assayed in Western analysis using the isoform-speciﬁc
peptide conjugated to BSA. None of the antisera had
any reactivity to BSA at the dilutions used (data not
shown). The speciﬁcity of the antibodies for the target
peptide sequence is shown in Fig. 11 A. The antisera pre-
pared using the PiT-1 peptide does not cross-react with
the peptide sequences used for PiT-2 or BNP-1. This lack
of cross-reactivity is also true for the other antisera. We
used the antisera to assay the expression of the three iso-
forms in rat brain and liver; these isoforms have been
previously demonstrated in these tissues by Northern
analysis (Kavanaugh et al., 1994) or RT-PCR (see above).
The antisera for PiT-1 detects an z70-kD polypeptide in
rat brain and liver (Fig. 11, B). However, the antisera
fails to detect the appropriate polypeptide in either hu-
man erythrocytes or K562 cells. The predicted molecu-
lar weight of this protein is 74 kD. Competition with the
immunizing peptide shows that the band detected is spe-
ciﬁc (data not shown). The antisera for PiT-2 detects an
z40-kD polypeptide in rat liver (Fig. 11, B) and the reac-
tivity for this polypeptide is speciﬁcally blocked with im-
munizing peptide (data not shown). However, the PiT-2
antisera does not detect any proteins in either K562 cells
or human erythrocytes. The predicted molecular weight
for PiT-2 is 70 kD, which is signiﬁcantly larger than the
protein detected in liver. We believe that this may be due
to PiT-2 sensitivity to proteolysis, despite the inclusion of
protease inhibitors in the extraction buffer used in these
experiments. The discrepancy in molecular weight re-
mains to be resolved. Finally, the antisera for BNP-1 de-
tects an z116-kD polypeptide in brain, liver, human
erythrocytes, and K562 cells. This apparent molecular
weight exceeds the predicted 61 kD without glycosyla-
tion. Similarly, NaPi-3 has an apparent molecular weight
of 125 kD by SDS-PAGE that exceeds the predicted 69
kD without glycosylation (Timmer and Gunn, 1998). Of
the three isoforms that were detected at the mRNA level
by RT-PCR, we can only detect the expression of the
BNP-1 polypeptide. We tentatively conclude that the Na-
dependent phosphate activity measured in K562 cells
arises principally from the BNP-1 isoform of the sodium-
phosphate cotransporter, despite the apparent expres-
sion of the mRNA for PiT-1, PiT-2, and BNP-1. Whether
or not the PiT-1 or PiT-2 polypeptides can be expressed
in K562 cells remains to be explored. It is possible that
the polypeptides for these proteins are synthesized in re-
sponse to certain environmental conditions (low or high
phosphate) or upon induction to the erythrocyte or leu-
kocyte phenotype.
Figure 10. Expression of so-
dium-phosphate cotransporter
isoforms in human tissues and
K562 cells as determined by PCR.
cDNA was obtained from CLON-
TECH Laboratories, Inc. for sev-
eral human tissues, including
kidney, brain, liver, and K562
cells. The templates used for the
given various PCR primers are in-
dicated above the gel image.
Primer pairs speciﬁc for the vari-
ous sodium-phosphate cotrans-
porter isoforms or GAPDH are
indicated above the gel image.
The primer pairs and their ex-
pected products were as follows (see Table I for description): (A) NaPi-3 (479 bp), (B) NaPi-10 (459 bp), (C) NaPi-10 (705 bp), (D) hBNP-1
(466 bp), (E) hBNP-1 (576 bp), (F) hPiT-1 (825 bp), (G) hPiT-1 (310 bp), (H) hPiT-2 (935 bp), and (I) GAPDH (452 bp).373 Timmer and Gunn
TABLE II
Peptides Used for Preparation of Isoform-specific Antibodies
Target isoform
Genbank
accession No. Peptide sequence*
Position in
human protein
Predicted to
cross-react with
rat isoform‡
hPiT-1 4885601 CEERTVSFKLGDLEEAPERER E313-R332 yes
hPiT2 5830173 CNAVAEAEIEAEEGGVEMKLASE N438-E459 yes§
hBNP-1 I59302 CYESPALHPSISEEERKYIED Y257-D276 yes
hNaPi-3i 4506985 CKLALEEEQKPESRLVPK K77-K93 yes¶
*The amino-terminal cysteine is not part of the native protein sequence and is added to the peptide only for conjugation to the carrier protein. ‡Unless
otherwise noted, the sequence is identical in rat or mouse. §The sequence “MKL” in the human sequence is “MRL” in the rat sequence. iPreparation of this
antibody was previously described (Timmer and Gunn, 1998). ¶The comparable sequence in rat is (bold indicates mismatches): KLAQEEEQKPEPRLSPK.
We have previously shown that this antibody specifically detects the appropriate polypeptide in rat kidney (Timmer and Gunn, 1998).
Figure 11. Expression of so-
dium-phosphate cotransporter
isoforms in human tissues and
K562 cells as determined by
Western analysis. (A) The speci-
ﬁcity of the antibodies for the an-
tigenic peptides was tested by
Western analysis of BSA-peptide
conjugates. The lanes are labeled
as follows: P1 (BSA-PiT-1 peptide
conjugate), P2 (BSA-PiT-2 pep-
tide conjugate), and P3 (BSA-
BNP-1 peptide conjugate). Each
lane was loaded with 1 ng of total
BSA-peptide conjugate. The blot
in  a  PiT-1 shows reactivity of
these BSA-peptide conjugates
with the anti–PiT-1 polyclonal an-
tibody prepared using a KLH-
PiT-1 peptide conjugate. The
other blots were developed using
the anti-PiT-2 polyclonal anti-
body (a PiT-2) or the anti–BNP-1
polyclonal antibody (a BNP-1).
The antibody dilution of the pri-
mary antibody used in all cases
was 1/1,000 of the crude sera.
(B) Whole cell lysates were pre-
pared from rat tissues, K562 cells
and human erythrocytes as de-
scribed in materials and meth-
ods. Total cell protein from
these samples were used for
Western analysis. The samples
are indicated at the top and are
as follows (left to right): K562,
which is K562 total cell protein
(10 mg); RBC, which is total hu-
man erythrocyte protein (10 mg);
liver, which is total rat liver pro-
tein (10 mg); and brain, which is total rat brain protein (10 mg). The blots were developed using the indicated polyclonal antibodies: a PiT-1,
the anti–PiT-1 polyclonal antibody; a PiT-2, the anti–PiT-2 polyclonal antibody; and a BNP-1, the anti–BNP-1 polyclonal antibody.374 Molecular Basis of Na-PO4 Cotransport in Erythrocytes
Ion Composition
The ion composition of erythrocytes is well known
(Funder and Wieth, 1966a,b). Although K562 cells have
been the subject of many papers, there are no measure-
ments of ionic composition reported. In Table III, there
are three experiments showing the composition of the
supernatants and cells after being washed in different
media, packed by centrifugation, and separately ana-
lyzed. K562 cells were washed in their culture medium
(RPMI) with fetal calf serum, isotonic MgCl2 (110 mM),
the NaCl ﬂux medium, or the N-methyl-glucamine Cl
preﬂux wash medium. After washing in the RPMI cul-
ture medium, the contents should reﬂect the steady
state values. However, the supernatant includes both
the composition of the wash medium and any ions lost
by the cells between the last wash and separating the su-
pernatant and packed cells. The loss of K from the cells
is apparent in the values measured in the supernatants
after the NaCl wash medium, where the supernatant K
all comes from the cells and was variable (Table III, 4.5
mM in experiment 2 and 23 mM in experiment 3) due
to different lengths of time between the last wash and
centrifugation. This variability is reciprocally displayed
in the cell K contents from these experiments (690
mmol/kg dry cell solid in experiment 2 and 650 in ex-
periment 3). Some of the variability between experi-
ments may arise from differences in the time of harvest
relative to the last split of the cultured cells (i.e.,
whether they were in log or stationary phase of growth).
In general, K562 cells are high K, low Na cells with in-
tracellular chloride at 50–60 mM, which is above elec-
trochemical equilibrium if the membrane potential is
more hyperpolarized than 215 mV. The apparent water
fraction (0.H2O) was constant (0.796–0.833), though
after correction for the concurrently measured 14C-inu-
lin or 14C-polyethylene trapped space, the water con-
tent, D gram of intracellular water/(gram dry cell sol-
ids), varied by 28%. The preﬂux wash reduced intracel-
lular sodium content and concentration by half, but
intracellular K, Cl, and PO4 remained relatively con-
stant. This reduction would increase the initial driving
for Na-phosphate inﬂux measured in NaCl medium.
DISCUSSION
All cells of the body, except erythrocytes, maintain in-
tracellular phosphate above electrochemical equilib-
rium using the inward sodium ﬂux down its gradient to
actively transport phosphate against its electrochemical
potential gradient. The inﬂux of 32PO4 into red cells is
normally by three pathways and, in plasma-like media
at 378C, the contributions of these three pathways are
as follows: (a) 70% is mediated by anion exchanger
AE1 (band 3) and can be blocked by DNDS or other
stilbene disulfonates; (b) 25% is sodium-dependent Na-
phosphate cotransport; and (c) 5% is by a pathway lin-
ear in extracellular phosphate concentration (up to 1
mM) (Gunn et al., 1989). In erythrocytes, only the
monovalent phosphate species is transported by AE1.
The phosphate is passively transported 2.83 faster by
AE1 than by the Na-PO4 cotransporter under physio-
logical conditions (Gunn et al., 1989). Thus, in erythro-
cytes, the steady state intracellular phosphate is close to
equilibrium with the plasma phosphate.
The molecular basis for the sodium-dependent phos-
phate ﬂux in erythrocytes has heretofore been un-
known and provided the rationale for this study. For
better or worse, erythrocytes are anucleated and thus
do not have RNA or DNA. This attribute helps to make
them ideally suited for detailed tracer transport mea-
surements, but poorly suited for many molecular bio-
logical manipulations. Although reticulocytes are a
commonly used nucleated model for erythrocytes, it is
very possible that the cotransport in reticulocytes is not
mediated by the same molecule as cotransport in ma-
ture erythrocytes. However, to determine whether a
cotransport activity in reticulocytes is the same as ma-
ture erythrocytes requires tracer inﬂux experiments,
and it is difﬁcult to obtain large numbers of pure reticu-
locytes required for such studies. Thus, we chose to ex-
amine a model cell that has similar cotransporter kinet-
ics and selectivity, is nucleated, and is easily obtained as
a homogeneous population. The model cell used in
these studies is the erythroleukemic cell line K562.
The results described above show that this cell line has
the kinetics of Na-PO4 cotransport that are the same as
in mature erythrocytes. We found, in K562 cells, that the
Na activation kinetics were sigmoidal (Fig. 5, bottom),
which led us to the careful reexamination of the Na acti-
vation kinetics in erythrocytes (Fig. 5, top). The clear sig-
moidal Na-activation kinetics in erythrocytes now sup-
ports a mechanism with two (or more) Na sites and
agrees with the previously observed stoichiometry of .1
Na per phosphate transported. There is no conﬂict be-
tween the data presented here and our previously re-
ported data (Shoemaker et al., 1988). In the previous
erythrocyte studies we reported that the ratio of the
[PO4]o-activated  22Na inﬂux and the [Na]o-activated
32PO4 inﬂux was 1.72 6 0.02 at three different pH values
and consequently a majority of the Na-PO4 cotransport
coupled 2 Na per phosphate (Shoemaker et al., 1988).
However, we also reported that Na-activation kinetics
were described by the Michaelis-Menten equation for a
single Na site. If the earlier data (Figure 4 in Shoemaker
et al., 1988) were graphed after being corrected for
the phosphate concentration used in the experiments
shown in Fig. 5, top, the data points would scatter along
the curve drawn in this ﬁgure. The sigmoidicity was not
previously noticed because there were too few data
points at low Na concentrations.375 Timmer and Gunn
We show above that phosphate transport in both
K562 cells is activated not only by sodium, but also by
lithium (Fig. 4). There is no signiﬁcant activation of
phosphate transport by any other cation tested (Fig. 4).
This pattern of cation activation is identical to that ob-
served for erythrocytes (S. Elmariah and R.B. Gunn,
manuscript in preparation). The lithium activation of
32PO4 inﬂux in K562 cells appears to have two separa-
ble components: a cooperative component similar to
the Na-activated 32PO4 inﬂux and a hyperbolic, saturat-
ing component. This second component of lithium ac-
tivation may arise either from a 1:1 cotransport mode
of the normally 2:1 cotransporter or from a different
cotransporter isoform. Alternatively, K562 cells may
have an additional lithium-phosphate cotransporter be-
sides hBNP-1, but it must be lithium speciﬁc since the
evidence is against any 1:1 Na-phosphate cotransport
(Fig. 5, bottom, inset). This additional cotransporter
must not be in erythrocytes since 1:1 cotransport of Li
or Na with phosphate is not apparent in the phosphate
kinetics measured in erythrocytes (Fig. 5, top, inset).
The pharmacological properties of the Na-depen-
dent phosphate transport activity in K562 cells and
erythrocytes are strikingly similar (Figs. 8, and 9). Previ-
ously, we reported that arsenate had a variable inhibi-
tory effect on erythrocyte Na-PO4 cotransport (Shoe-
maker et al., 1988), but this may have been due to un-
compensated pH changes in those experiments. It was
the marked arsenate inhibition of phosphate transport
by K562 cells (Fig. 7) that motivated a more careful
study in erythrocytes that conﬁrmed the similarity of ar-
senate inhibition in these two systems (S. Elmariah and
R.B. Gunn, manuscript in preparation). In erythro-
cytes, the Na-activated 32PO4 inﬂux is the same in the
absence and presence of 0.25 mM DNDS (Shoemaker
et al., 1988) thus the cotransporter is not blocked by
this compound, although .99% of the chloride and
phosphate transport on AE1 is blocked. Other com-
pounds tested (pCMBS at 0.1 mM, phloretin at 0.1 mM,
vanadate at 1 mM, and PFA at 1 mM; Fig. 9) showed
very similar effects on the Na-dependent phosphate
transport in both K562 cells and erythrocytes.
The above data suggests that the Na-dependent phos-
phate transport activities in K562 cells and erythrocytes
are kinetically similar, thus supporting a common molec-
ular identity for the cotransporter in these two cell types.
We then determined which speciﬁc cotransporter iso-
form mRNAs were expressed in K562 cells and found
that these cells express mRNA for three human Na-phos-
phate cotransporters: hBNP-1, hPiT-1, and hPiT-2 (Fig.
10). It may also express the mRNA from an unknown Na-
PO4 cotransporter gene. Antibodies to hBNP-1, hPiT-1,
and hPiT-2 react only with BSA conjugated to the peptide
sequence used as the antigen in their preparation (Fig.
TABLE III
Composition of K562 Cells and the Supernatant after Washing and Packing
Supernatants (mM) Water Content and Trapped Space
Experiment Wash medium Na K Cl PO4 0.H20 D
Trapped
space
1 RPMI 118 8.6 100 32.4 0.833 5.00 0.097
MgCl2 2.6 7.0 205 33.5 0.829 4.83 0.084
2 NaCl 135 4.5 146 41.8 0.796 3.91 0.117
NMDG Cl 3.6 3.2 131 41.7 0.799 3.98 0.118
3 NaCl 132 23 145 34.9 0.804 4.09 0.095
NMDG Cl 2.5 6.7 128 35.5 0.804 4.11 0.106
Packed Cell Intracellular Concentration and Content
Experiment
Wash
medium
Na
mM
Na
content
K
mM
K
content
Cl
mM
Cl 
content
PO4
mM
PO4
content
1 RPMI 27 135 133 660 56 280 32.4 162
MgCl2 26 125 133 640 58 280 33.5 162
2 NaCl 28 111 176 690 63 250 41.8 164
NMDG Cl 17 67 167 660 54 220 41.7 166
3 NaCl 31 125 159 650 60 250 34.9 143
NMDG Cl 12 51 152 630 51 210 35.5 146
0.H20 is the water fraction corrected for trapped space. D is the grams of intracellular water/grams of dry cell solids. Trapped space is the grams of plasma
space/grams wet packed cells, the average of duplicate measurements on packed cells centrifuged concurrently with the other cells analyzed for water and
ions. K562 cells were washed in the indicated medium (see materials and methods) three times and packed in duplicate tubes. The RPMI and MgCl2
experiments were performed on paired aliquots of the same cell suspension. Each NaCl and NMDG Cl experiment below it were performed on aliquots
of the same cell suspension on the same day. The values are the means of the duplicates that differed by no more than two in the least significant figure.
Ion concentrations in millimoles per kilogram cell water, contents in millimoles per kilogram dry cell solids.376 Molecular Basis of Na-PO4 Cotransport in Erythrocytes
11). Both erythrocyte and K562 cells only react with the
anti–hBNP-1 antibody. Although the positive controls for
all three antibodies demonstrated they could identify
their appropriate substrates in other tissues, the absence
of any detectable hPiT-1 or hPiT-2 in erythrocytes or
K562 cells does not prove they are absent, but does sug-
gest they are of much lower abundance than hBNP-1.
In summary, we made the following observations on
K562 cells: (a) the kinetics and pharmacology of Na-
PO4 cotransport in these cells are the same as in mature
erythrocytes; (b) K562 cells and erythrocytes have sig-
niﬁcant Li-activated 32PO4 inﬂux, whereas the (Type II)
renal isoforms and hPiT-1 do not; (c) RT-PCR shows
that the mRNA for hBNP-1, hPiT-1, and hPiT-2 are the
only sodium-phosphate cotransporters expressed in
these cells; and (d) Western analysis shows that only
hBNP-1 is the only sodium-phosphate cotransporter iso-
form polypeptide that can be detected in erythrocyte
membranes and K562 cell membranes. Since both
erythrocytes and K562 cells are shown here to have only
hBNP-1 protein by Western analysis and the two cell
types have similar transport kinetics, it seems likely that
these similarities are caused by the presence of hBNP-
1–mediated transport kinetics. Thus, we tentatively con-
clude that the erythrocyte sodium-phosphate cotrans-
porter is the same as hBNP-1. But this conclusion re-
quires additional experiments; e.g., heterologous ex-
pression and kinetic characterization of hBNP-1.
The other supportive evidence for this conclusion is
the exclusion of both hNaPi-3 and hPiT-1 based upon
their previously reported functional properties. For ex-
ample, the expression of hPiT-1 in oocytes induces ex-
ternal Na-activated inward current in the presence of ex-
ternal phosphate but no external Li-activated inward
current (Olah et al., 1994). This suggests that Li is not a
substrate for hPiT-1, unlike the cotransporter in erythro-
cytes and K562 cells. Therefore, although mRNA for
hPiT-1 was found in K562 cells, the apparent absence of
hPiT-1 protein in K562 cells and erythrocytes is consis-
tent with some other isoform mediating the Li-PO4
cotransport in these cells. Although Na-PO4 cotransport
in K562 cells (Fig. 10) and in HEK 293 cells expressing
NaPi-3 share some similar pharmacology (e.g., both are
not inhibited by DNDS, equally inhibited by phloretin
(50% at 0.1 mM) and are equally inhibited by pCMBS
(.90% at 1 mM) (Timmer and Gunn, 1998), these
cotransport activities have some distinct pharmacology.
For example, PFA and vanadate had little effect on ei-
ther erythrocytes or K562 cells, but are signiﬁcant inhib-
itors of NaPi-3 expressed in HEK 293 cells (Timmer and
Gunn, 1998) and NaPi-3 (or the rat homolog) in cortical
brush border membranes (PFA: Ki
rat 5 4.6 3 1024 M,
Szczepanska-Konkel et al., 1986; Ki
rat 5 2.1 3 1024 M
and Ki
human 5 3.1 3 1025 M, Yusuﬁ et al., 1986). These
differences rule out NaPi-3 as a candidate for the K562
and erythrocyte cotransporter. As shown in Table IV, the
characteristics of the different isoforms when expressed
in different systems do not always agree. The differences
between hNaPi-3 and the form in erythrocytes as de-
scribed above are apparent. But the kinetic differences
between hPiT-1 and rPiT-2 expressed in oocytes and that
of erythrocytes are probably insufﬁcient to exclude
them as candidates in those cells, except the apparent
absence of Li as a substrate in hPiT-1. Unfortunately,
there are no kinetic or pharmacological studies of native
or expressed hPiT-2 or hBNP-1. A side-by-side study of
their kinetics and pharmacology in a common expres-
sion system could strengthen the identiﬁcation of hBNP-1
as the K562 and erythrocyte Na-PO4 cotransporter.
The results of this study are signiﬁcant for two reasons.
First, the apparent expression of a single Na-PO4 cotrans-
porter, hBNP-1, in erythrocytes and K562 cells potentially
provides a native cell system in which to characterize the
isoform-speciﬁc kinetics as reported here. In addition,
this suggests a native cell system to study the isoform-spe-
ciﬁc regulation of phosphate transport in future studies.
The predominance of rPiT-2 expression in rat ﬁbroblasts
provides another system for the study of isoform-speciﬁc
characteristics (Kavanaugh et al., 1994). However, many
cells express multiple isoforms of Na-phosphate cotrans-
porters. The mechanisms by which cells control their in-
tracellular phosphate concentration are poorly under-
stood, though changes in plasma phosphate concentra-
tion alter cell metabolism, presumably through altering
cytoplasmic phosphate activity and cytoplasmic phos-
phoryl potential. Since the Na-phosphate cotransport
mechanisms use the energy in the Na gradient, they are
probably closely regulated. Second, there is the sugges-
tion that the erythrocyte Na-phosphate cotransporter is
the molecular basis for Na–Li exchange in red cells. This
suggestion is based in part upon the observation that the
Na-phosphate cotransporter mediates Li-phosphate co-
transport (Fig. 4). In addition, a Na-dependent cotrans-
porter can mediate cation–cation exchange through a
slippage mechanism when only a cation, but no phos-
phate, is bound. For example, the rat homolog of NaPi-3
can mediate Na–Na exchange (Forster et al., 1998), and
the Na-PO4 cotransporter (hBNP-1) in erythrocytes can
mediate Na–Li exchange (S. Elmariah and R.B. Gunn,
manuscript in preparation). Thus, hBNP-1 function may
extend beyond the transport of phosphate to include
lithium transport and its therapeutic efﬁcacy in neurons
and glia that express this Na-phosphate cotransporter.
Proof that hBNP-1 is also the molecular mechanism of
Na–Li exchange in red cells is beyond the scope of this
paper and is the subject of current studies in progress.
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